Corentec
코렌텍 · 104540
Health Care Medical Devices · KOSDAQ
Market cap US$40.9M (₩56.4B)
Overview
Corentec makes artificial joints, replacement hip and knee implants used in orthopaedic surgery, and is listed on KOSDAQ, South Korea's tech and small-cap exchange.
Its products are supplied to hospitals and surgical facilities, including through a dedicated US subsidiary, Corentec America. The company describes itself as the first domestic Korean manufacturer specialised in artificial joints and holds proprietary surface-treatment and design technologies; it was also the first in the world to apply three-dimensional printing technology to artificial-joint production.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$66.7M
- FY2024US$67.9M
- FY2025US$72.8M
Operating profit
- FY2023US$5.1M
- FY2024US$2.8M
- FY2025US$6.6M
Net income
- FY2023US$3.7M
- FY2024−US$959.3K
- FY2025US$5.1M
Key ratios (FY2025)
Why it matters
Corentec consolidates two main subsidiaries, Corentec America for US distribution and Sunhealthcare International, which operates health-screening services and a US orthopaedic surgery hospital, under its group structure.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?